Emvita 13 (RUBIMED AG)


Welcome to the PulseAid listing for the Emvita 13 drug offered from RUBIMED AG. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: RUBIMED AG
NON-PROPRIETARY NAME: Bothrops Atrox Venom, Oyster shell calcium carbonate, crude, Graphite, Anacardium Occidentale Fruit, and Sus Scrofa Thymus
SUBSTANCE NAME: BOTHROPS ATROX VENOM; OYSTER SHELL CALCIUM CARBONATE, CRUDE; GRAPHITE; ANACARDIUM OCCIDENTALE FRUIT; SUS SCROFA THYMUS
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: LIQUID
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2015-05-07
END MARKETING DATE: 0000-00-00


Emvita 13 HUMAN OTC DRUG Details:

Item DescriptionEmvita 13 from RUBIMED AG
LABELER NAME: RUBIMED AG
DEA SCHEDULE:
ACTIVE STRENGTH: 800; 16; 18; 21; 21([hp_C]/mL; [hp_M]/mL; [hp_M]/mL; [hp_X]/mL; [hp_X]/mL)
START MARKETING DATE: 2015-05-07
END MARKETING DATE: 0000-00-00
PRODUCT ID: 66343-025_5d8011c3-fa3e-4fc5-8432-ee66198f3a69
PRODUCT NDC: 66343-025
APPLICATION NUMBER:

Other BOTHROPS ATROX VENOM; OYSTER SHELL CALCIUM CARBONATE, CRUDE; GRAPHITE; ANACARDIUM OCCIDENTALE FRUIT; SUS SCROFA THYMUS Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
RUBIMED AGEmvita 13